Genomic Valley Biotech (BOM:539206) 3-Year EBITDA Growth Rate : 0.00% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Genomic Valley Biotech 3-Year EBITDA Growth Rate?

Genomic Valley Biotech's EBITDA per Share for the three months ended in Mar. 2024 was ₹-0.18.

During the past 12 months, Genomic Valley Biotech's average EBITDA Per Share Growth Rate was -97.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Genomic Valley Biotech was 64.80% per year. The lowest was -34.00% per year. And the median was 4.70% per year.

Competitive Comparison of Genomic Valley Biotech's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Genomic Valley Biotech's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genomic Valley Biotech's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genomic Valley Biotech's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Genomic Valley Biotech's 3-Year EBITDA Growth Rate falls into.

Genomic Valley Biotech 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Genomic Valley Biotech (BOM:539206) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Genomic Valley Biotech 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Genomic Valley Biotech's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomic Valley Biotech (BOM:539206) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genomic Valley Biotech Ltd (BOM:539206) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 K.M. Stone, Berri Charra Road, P.O. Tandaheri, Tehsil-Bahadurgarh, Village Kherka Musalman, Jhajjar, HR, IND, 124507

Website

http://www.genomicvalley.com

Genomic Valley Biotech Ltd is an India-based company engaged in providing diagnostic services and related business services. It undertakes commercial production of plant tissue cultured plants of different species to feed the genetically improved plant market nationally as well as internationally. The group conducts research in the field of agriculture, plant tissue culture, medical biotechnology, SERI biotechnology, stem cell, food biotechnology, Drone technology, Poly House Construction, and others. It generates revenue from the sale of services.

Genomic Valley Biotech (BOM:539206) Headlines

No Headlines